The ENPP1 Gene Arterial Calcification Type 1 Generalized Infantile Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE. This test is designed to identify mutations in the ENPP1 gene, which are linked to Generalized Arterial Calcification of Infancy (GACI) Type 1, a rare genetic disorder. GACI Type 1 is characterized by extensive calcification of the arteries, leading to reduced blood flow and potentially life-threatening complications from an early age. The ENPP1 gene plays a crucial role in regulating mineralization; thus, mutations can lead to abnormal calcium deposits in the blood vessels.
Priced at 4400 AED, the test involves analyzing the patient's DNA to detect any genetic alterations in the ENPP1 gene. Early detection through this genetic test can be pivotal in managing the condition, guiding treatment options, and providing essential information for family planning. Conducted at the state-of-the-art facilities of DNA Labs UAE, this test is a critical tool for families at risk of GACI Type 1, offering hope through early intervention and the potential for targeted therapies.
The ABCC6 gene plays a critical role in the regulation of calcium and phosphate levels in the body, influencing the development and maintenance of healthy tissues, including the arteries. Mutations in the ABCC6 gene can lead to a rare genetic disorder known as Generalized Arterial Calcification of Infancy Type 2 (GACI Type 2). This condition is characterized by extensive calcification of the arteries, which can lead to cardiovascular issues early in life, including heart attacks and strokes, even in infancy or childhood.
To diagnose this condition accurately and promptly, genetic testing targeting the ABCC6 gene is crucial. DNA Labs UAE offers a comprehensive genetic test specifically designed to identify mutations in the ABCC6 gene that are associated with Generalized Arterial Calcification of Infancy Type 2. This test is an invaluable tool for early detection, allowing for timely intervention and management of the condition to prevent severe complications.
The test is priced at 4400 AED and involves collecting a DNA sample from the patient, typically through a blood draw or a cheek swab. The sample is then analyzed in the laboratory using advanced genetic sequencing technologies to detect any mutations in the ABCC6 gene. Results from this test can provide essential information for families affected by GACI Type 2, including risk assessment for family members and potential treatment options to manage the condition.
Given the rare nature of GACI Type 2 and the specialized testing required, DNA Labs UAE plays a crucial role in providing access to this important diagnostic tool within the region, supporting affected families in navigating the challenges associated with this genetic condition.
The SLC2A10 gene arterial tortuosity syndrome genetic test is a specialized diagnostic procedure designed to identify mutations in the SLC2A10 gene, which are responsible for causing arterial tortuosity syndrome (ATS). This condition is characterized by the twisting and elongation of the arteries, leading to a range of cardiovascular complications. Symptoms can include hypertension, aneurysms, and arterial stenosis, making early detection and management crucial for affected individuals.
The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in a laboratory setting to detect any genetic abnormalities in the SLC2A10 gene. By identifying these mutations, healthcare providers can confirm a diagnosis of arterial tortuosity syndrome, enabling them to develop a tailored management plan that may include regular monitoring, lifestyle adjustments, and potentially preventative surgeries to mitigate the risk of serious cardiovascular events.
Offered at DNA Labs UAE, the cost of the SLC2A10 gene arterial tortuosity syndrome genetic test is 3200 AED. DNA Labs UAE is known for its state-of-the-art facilities and expertise in genetic testing, providing accurate and reliable results. This test is a valuable resource for individuals with a family history of ATS or those exhibiting symptoms suggestive of the condition, facilitating early intervention and improved outcomes.
The SOAT1 gene, also known as Sterol O-acyltransferase 1, plays a crucial role in the body's lipid metabolism process, particularly in the formation of cholesteryl esters from cholesterol. Mutations or variations in the SOAT1 gene have been linked to the development of atherosclerosis, a condition characterized by the buildup of fats, cholesterol, and other substances on the artery walls, which can lead to heart disease, stroke, and other cardiovascular issues.
To assess the risk of atherosclerosis linked to genetic factors, DNA Labs UAE offers a specialized genetic test targeting the SOAT1 gene. This test is designed to identify specific mutations or variations in the SOAT1 gene that may increase an individual's susceptibility to atherosclerosis. By understanding one's genetic predisposition, individuals can take proactive measures to manage their risk through lifestyle changes, medical interventions, and regular monitoring.
The test is priced at 4400 AED and involves a simple procedure where a sample of the individual's DNA is collected, usually through a blood draw or a cheek swab. The sample is then analyzed in the laboratory to detect any genetic variations in the SOAT1 gene that are associated with an increased risk of atherosclerosis.
DNA Labs UAE is equipped with state-of-the-art technology and staffed by professionals with expertise in genetic testing and analysis. The results from the SOAT1-related genetic test can provide valuable insights into an individual's genetic predisposition to atherosclerosis, aiding in the early detection and prevention of cardiovascular diseases. It's an important tool for individuals with a family history of heart disease or those who want to understand their genetic risk factors for atherosclerosis.
The GP1BA Gene Bernard Soulier Syndrome Type A1 Genetic Test is a specialized diagnostic examination available at DNA Labs UAE. Priced at 4400 AED, this test is specifically designed to identify mutations in the GP1BA gene, which are indicative of Bernard-Soulier Syndrome Type A1 (BSS Type A1). BSS Type A1 is a rare inherited blood disorder characterized by a deficiency of glycoprotein Ib, a crucial component of platelet function necessary for normal blood clotting. Individuals with this syndrome often exhibit symptoms such as prolonged bleeding times, easy bruising, and abnormal platelet function.
The test involves collecting a DNA sample from the patient, typically through a blood draw, which is then analyzed in the lab for genetic anomalies associated with the condition. The results from this test can provide essential information for the diagnosis, management, and treatment planning for individuals suspected of having Bernard-Soulier Syndrome Type A1, enabling healthcare providers to offer targeted interventions to mitigate the symptoms and improve the quality of life for affected individuals. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals to ensure accurate and reliable test results.
The ALDH1A2 gene plays a crucial role in the development of the heart during the fetal stage. Mutations in this gene have been associated with congenital heart defects, including Tetralogy of Fallot (TOF), which is a complex heart condition characterized by four specific heart defects that occur together. The ALDH1A2 Gene Tetralogy of Fallot Genetic Test is a specialized diagnostic tool designed to identify mutations in the ALDH1A2 gene that could be responsible for TOF. This test is particularly important for individuals with a family history of TOF or related heart defects, as it can provide crucial information for early diagnosis and management of the condition.
The test is conducted at DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the test is 4400 AED, reflecting the intricate technology and expertise required to accurately identify and analyze genetic mutations associated with Tetralogy of Fallot. By opting for this test, individuals can gain valuable insights into their genetic predisposition to TOF, enabling informed decisions regarding their health and the health of their future offspring. DNA Labs UAE ensures confidentiality and accuracy, providing a comprehensive support system for individuals undergoing genetic testing.
The "GATA4 Gene Tetralogy of Fallot Genetic Test" is a specialized diagnostic procedure aimed at identifying mutations in the GATA4 gene, which is linked to Tetralogy of Fallot (TOF), a complex congenital heart defect. This genetic condition affects the structure of the heart, leading to poor oxygenation of blood and significant health challenges. The test is crucial for early detection, allowing for timely intervention and management strategies to be implemented, improving the quality of life and outcomes for affected individuals.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services, the test provides a comprehensive analysis of the GATA4 gene. By examining the specific DNA sequences, the test can pinpoint mutations that are associated with the development of TOF, offering valuable insights for families and healthcare providers.
The cost of the test is set at 4400 AED, reflecting the intricate processes and sophisticated technology employed in identifying the genetic underpinnings of this heart condition. Opting for this test at DNA Labs UAE ensures accuracy, reliability, and confidentiality, supported by a team of genetic experts and counselors who can guide patients through the results and subsequent steps.
The "GATA6 Gene Tetralogy of Fallot Genetic Test" is a specialized diagnostic examination conducted to identify mutations in the GATA6 gene, which have been associated with Tetralogy of Fallot (TOF), a complex congenital heart defect. This genetic test is crucial for early detection and management of TOF, enabling healthcare providers to develop a tailored treatment plan that addresses the specific needs of the patient. The test is available at DNA Labs UAE, a leading facility in genetic diagnostics, ensuring high accuracy and reliability of results. The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to perform this sophisticated analysis. By opting for this test, patients and their families can gain valuable insights into the genetic underpinnings of TOF, facilitating informed decisions about care and management options.
The ZFPM2 Gene Tetralogy of Fallot Genetic Test is a specialized diagnostic tool used to identify mutations in the ZFPM2 gene, which have been linked to Tetralogy of Fallot (TOF), a complex congenital heart defect. This test is crucial for understanding the genetic underpinnings of TOF and can provide valuable information for affected families regarding the risk of recurrence in future pregnancies. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw, and analyzing it for specific genetic alterations associated with the condition. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the ZFPM2 gene. This genetic test is an important step towards personalized medicine, offering insights that can guide clinical decisions and management strategies for individuals with Tetralogy of Fallot.
The "SMAD2 Gene Thoracic Aortic Aneurysm Dissection Genetic Test" is a specialized diagnostic procedure aimed at identifying mutations in the SMAD2 gene, which have been associated with an increased risk of developing thoracic aortic aneurysms and dissections. Thoracic aortic aneurysms and dissections (TAAD) are serious conditions characterized by the weakening and potential rupture of the aorta in the chest area, leading to life-threatening complications.
The test is conducted by DNA Labs UAE, a reputable facility known for its advanced genetic testing services. By analyzing a sample of the patient's DNA, the test can pinpoint specific genetic alterations in the SMAD2 gene that may predispose individuals to TAAD. This information is crucial for early detection, risk assessment, and the implementation of preventative strategies or surveillance measures to mitigate the risks associated with these conditions.
The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify genetic mutations and provide valuable insights into an individual's risk profile for thoracic aortic aneurysms and dissections. By opting for this test, individuals with a family history or other risk factors for TAAD can take an important step towards proactive health management and potentially life-saving interventions.
